These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26108435)

  • 1. Oral contraceptive study omitted several confounders.
    Zagarella SS
    BMJ; 2015 Jun; 350():h3303. PubMed ID: 26108435
    [No Abstract]   [Full Text] [Related]  

  • 2. Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism.
    Jick SS
    BMJ; 2015 May; 350():h2422. PubMed ID: 26013974
    [No Abstract]   [Full Text] [Related]  

  • 3. New study supports MHRA advice on combined oral contraceptives.
    Harrison-Woolrych M; Woolley J
    BMJ; 2015 Jun; 350():h3305. PubMed ID: 26108434
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills.
    Plu-Bureau G
    Evid Based Med; 2015 Oct; 20(5):189. PubMed ID: 26269361
    [No Abstract]   [Full Text] [Related]  

  • 5. Authors' reply to Zagarella.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 Jun; 350():h3308. PubMed ID: 26109585
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the removal of optionally retrievable caval filters: are we there yet?
    Janne d'Othée B
    J Vasc Interv Radiol; 2013 Jan; 24(1):40-2. PubMed ID: 23273696
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of the contraceptive pill and venous thromboembolism.
    Hannaford PC
    Thromb Res; 2011 Feb; 127 Suppl 3():S30-4. PubMed ID: 21262435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination oral contraceptives and the risk of venous thromboembolism.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):23-4. PubMed ID: 20336034
    [No Abstract]   [Full Text] [Related]  

  • 10. Variations in Peripherally Inserted Central Catheter Use and Outcomes in Michigan Hospitals.
    Chopra V; Smith S; Swaminathan L; Boldenow T; Kaatz S; Bernstein SJ; Flanders SA
    JAMA Intern Med; 2016 Apr; 176(4):548-51. PubMed ID: 26881938
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of CSM's warning about safety of third generation oral contraceptive. General practitioners in England prescribed second generation pills instead.
    Ferguson J; Jenkins MG
    BMJ; 1996 Aug; 313(7053):363. PubMed ID: 8760758
    [No Abstract]   [Full Text] [Related]  

  • 12. Introducing a specialist drug kardex can significantly change prescribing practices for VTE in cancer patients.
    Coleman N; Young R; Greally M; O'Riordan L; Breathnach O; Grogan L
    Ir Med J; 2014 Jun; 107(6):188. PubMed ID: 24988843
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-partum contraception: Guidelines for clinical practice].
    Raccah-Tebeka B; Plu-Bureau G
    J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1127-34. PubMed ID: 26527021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptives for acne treatment: US Dermatologists' knowledge, comfort, and prescribing practices.
    Fitzpatrick L; Mauer E; Chen CL
    Cutis; 2017 Mar; 99(3):195-201. PubMed ID: 28398414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients.
    Matzdorff A; Ledig B; Stuecker M; Riess H
    Oncol Res Treat; 2016; 39(4):194-201. PubMed ID: 27160305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance.
    Mueck AO
    Menopause; 2010; 17(6):1099-103. PubMed ID: 20975607
    [No Abstract]   [Full Text] [Related]  

  • 20. How should we advise patients about the contraceptive patch, given the FDA warning?
    Thacker HL; Falcone T; Atreja A; Jain A; Harris CM
    Cleve Clin J Med; 2006 Jan; 73(1):45-7. PubMed ID: 16444915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.